MITANT 12.5MG CAPSULE 7'S

Yes, MITANT 12.5MG CAPSULE 7'S can cause changes in skin color. One common side effect is called "hand-foot syndrome," which can cause redness, swelling, and pain in the palms of the hands and soles of the feet. This syndrome can sometimes cause the skin to darken or become thickened in these areas. Additionally, this medication can cause other skin changes, such as rashes and discoloration.

Yes, MITANT 12.5MG CAPSULE 7'S can cause heart problems such as high blood pressure, heart failure, and heart attack. Patients taking this medication should be closely monitored by their healthcare provider for any signs of heart problems and may need to undergo regular heart function tests.

Yes, MITANT 12.5MG CAPSULE 7'S can cause kidney problems such as proteinuria (excess protein in the urine) and renal impairment. Patients taking this medication require regular monitoring of kidney function and need to adjust the dosage or switch to a different medication if these side effects occur or persist.

Yes, but your healthcare provider will monitor your thyroid function regularly. MITANT 12.5MG CAPSULE 7'S can affect the thyroid gland, causing hypothyroidism (an underactive thyroid gland) or hyperthyroidism (an overactive thyroid gland). Therefore, your healthcare provider will check thyroid hormone levels in your blood before starting treatment and periodically during treatment.

Yes, MITANT 12.5MG CAPSULE 7'S can affect fertility in both men and women. Patients taking this medication should discuss the potential risks and options for preserving fertility with their healthcare provider before starting treatment.

MITANT 12.5MG CAPSULE 7'S can cause hematologic toxicity, which may include neutropenia (low white blood cell count), thrombocytopenia (low platelet count), and anemia (low red blood cell count). These changes can increase the risk of infection, bleeding, and fatigue.

There is no specific information available about how MITANT 12.5MG CAPSULE 7'S interacts with other drugs. It is always important to consult with a doctor before starting any medication.

If you have been prescribed MITANT 12.5MG CAPSULE 7'S, it is important to follow your healthcare provider's instructions. During treatment, avoid taking grapefruit or grapefruit juice as it can increase the levels of medication in the blood and potentially increase the risk of side effects. Use a reliable method of birth control while taking the medication and for at least four weeks after the last dose. This medication can cause serious side effects, so it is important to be vigilant and informed about your treatment. Make sure to report any symptoms or changes in your health, even if they seem minor. Proper precautions and monitoring can be an effective treatment for certain types of cancer.

SUNITINIB is the molecule/combination used for making MITANT 12.5MG CAPSULE 7'S.

MITANT 12.5MG CAPSULE 7'S is prescribed for ailments/diseases/conditions related to Oncology.